Cytokines such as interleukin 2 (IL-2) and granulocyte-macrophage colony-stimulating factor (GM-CSF) were among the first intratumoral regimens assessed in melanoma [77,78] (Figure 1d). This evidence concerns the gene CSF2 and melanoma.